

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.51835231 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.51835231 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.26873149 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26873149 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.62320798 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.85309609 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.85309609 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.85309609 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.78290612 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.67291089 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.67109749 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.58884409 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.53234523 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 5.29242533 |
| 15 | cysteine metabolic process (GO:0006534) | 5.25555603 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.05832927 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.04304790 |
| 18 | urea metabolic process (GO:0019627) | 4.99106431 |
| 19 | urea cycle (GO:0000050) | 4.99106431 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.98851498 |
| 21 | serine family amino acid catabolic process (GO:0009071) | 4.90732964 |
| 22 | protein carboxylation (GO:0018214) | 4.88156871 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88156871 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 4.86792699 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.84925348 |
| 26 | bile acid metabolic process (GO:0008206) | 4.75028342 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69388130 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.68245558 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.67145952 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.66207083 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 4.64990437 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.61821259 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.58110936 |
| 34 | tyrosine metabolic process (GO:0006570) | 4.56408742 |
| 35 | alpha-amino acid catabolic process (GO:1901606) | 4.52442896 |
| 36 | aldehyde catabolic process (GO:0046185) | 4.50088286 |
| 37 | cellular ketone body metabolic process (GO:0046950) | 4.44615798 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.40022522 |
| 39 | lysine metabolic process (GO:0006553) | 4.38627841 |
| 40 | lysine catabolic process (GO:0006554) | 4.38627841 |
| 41 | regulation of complement activation (GO:0030449) | 4.37216870 |
| 42 | serine family amino acid biosynthetic process (GO:0009070) | 4.36928789 |
| 43 | glycine metabolic process (GO:0006544) | 4.36266063 |
| 44 | serine family amino acid metabolic process (GO:0009069) | 4.32242183 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.27652280 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.24672804 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.24672804 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.24672804 |
| 49 | coenzyme catabolic process (GO:0009109) | 4.21798001 |
| 50 | cellular amino acid catabolic process (GO:0009063) | 4.21724698 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.18587899 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.18587899 |
| 53 | cellular biogenic amine catabolic process (GO:0042402) | 4.18234375 |
| 54 | amine catabolic process (GO:0009310) | 4.18234375 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 4.17110488 |
| 56 | metallo-sulfur cluster assembly (GO:0031163) | 4.17078842 |
| 57 | iron-sulfur cluster assembly (GO:0016226) | 4.17078842 |
| 58 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.16611353 |
| 59 | phosphatidylglycerol biosynthetic process (GO:0006655) | 4.09309583 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 4.09275591 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.09275591 |
| 62 | imidazole-containing compound metabolic process (GO:0052803) | 4.02009084 |
| 63 | phospholipid efflux (GO:0033700) | 3.99632967 |
| 64 | ethanol oxidation (GO:0006069) | 3.98299042 |
| 65 | cellular glucuronidation (GO:0052695) | 3.97618682 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 3.97050744 |
| 67 | autophagic vacuole fusion (GO:0000046) | 3.96859415 |
| 68 | bile acid and bile salt transport (GO:0015721) | 3.96597035 |
| 69 | cofactor catabolic process (GO:0051187) | 3.95650439 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.92208834 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.89388257 |
| 72 | drug catabolic process (GO:0042737) | 3.86482331 |
| 73 | short-chain fatty acid metabolic process (GO:0046459) | 3.85139610 |
| 74 | glutamate metabolic process (GO:0006536) | 3.83477321 |
| 75 | ketone body metabolic process (GO:1902224) | 3.83298209 |
| 76 | arginine metabolic process (GO:0006525) | 3.80660599 |
| 77 | cholesterol efflux (GO:0033344) | 3.79137993 |
| 78 | fibrinolysis (GO:0042730) | 3.78752262 |
| 79 | carboxylic acid catabolic process (GO:0046395) | 3.75652902 |
| 80 | organic acid catabolic process (GO:0016054) | 3.75652902 |
| 81 | L-serine metabolic process (GO:0006563) | 3.67789309 |
| 82 | blood coagulation, intrinsic pathway (GO:0007597) | 3.66156486 |
| 83 | heme transport (GO:0015886) | 3.65954590 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.64745784 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.64745784 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.62701573 |
| 87 | uronic acid metabolic process (GO:0006063) | 3.62701573 |
| 88 | drug transmembrane transport (GO:0006855) | 3.62481438 |
| 89 | acetyl-CoA metabolic process (GO:0006084) | 3.61647911 |
| 90 | aspartate family amino acid catabolic process (GO:0009068) | 3.58273108 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.56486794 |
| 92 | NAD biosynthetic process (GO:0009435) | 3.56454233 |
| 93 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.56057728 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.52252592 |
| 95 | urate metabolic process (GO:0046415) | 3.51814891 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 3.51037717 |
| 97 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.49347304 |
| 98 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.49347304 |
| 99 | response to nitrosative stress (GO:0051409) | 3.49096563 |
| 100 | fatty acid beta-oxidation (GO:0006635) | 3.47334252 |
| 101 | exogenous drug catabolic process (GO:0042738) | 3.46750683 |
| 102 | very long-chain fatty acid metabolic process (GO:0000038) | 3.45982071 |
| 103 | drug metabolic process (GO:0017144) | 3.45157536 |
| 104 | sterol homeostasis (GO:0055092) | 3.44912908 |
| 105 | regulation of bile acid biosynthetic process (GO:0070857) | 3.43942171 |
| 106 | response to misfolded protein (GO:0051788) | 3.34055511 |
| 107 | protein complex biogenesis (GO:0070271) | 3.23652321 |
| 108 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.22801070 |
| 109 | deoxyribonucleotide catabolic process (GO:0009264) | 3.20626288 |
| 110 | cytochrome complex assembly (GO:0017004) | 3.20184279 |
| 111 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.09786283 |
| 112 | seminiferous tubule development (GO:0072520) | 3.08683957 |
| 113 | valine metabolic process (GO:0006573) | 3.03490410 |
| 114 | mitochondrial calcium ion transport (GO:0006851) | 3.02928092 |
| 115 | base-excision repair, AP site formation (GO:0006285) | 2.93318377 |
| 116 | arginine catabolic process (GO:0006527) | 2.91437235 |
| 117 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.89352787 |
| 118 | deoxyribose phosphate catabolic process (GO:0046386) | 2.88142308 |
| 119 | heme metabolic process (GO:0042168) | 2.86811610 |
| 120 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.85740312 |
| 121 | organelle membrane fusion (GO:0090174) | 2.79178070 |
| 122 | xenobiotic catabolic process (GO:0042178) | 2.78801045 |
| 123 | mannosylation (GO:0097502) | 2.78527343 |
| 124 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.78477711 |
| 125 | positive regulation of mitochondrial fission (GO:0090141) | 2.78431157 |
| 126 | heme biosynthetic process (GO:0006783) | 2.78420779 |
| 127 | GDP-mannose metabolic process (GO:0019673) | 2.76594947 |
| 128 | cholesterol catabolic process (GO:0006707) | 2.76435190 |
| 129 | sterol catabolic process (GO:0016127) | 2.76435190 |
| 130 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.75729947 |
| 131 | NADH dehydrogenase complex assembly (GO:0010257) | 2.75729947 |
| 132 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.75729947 |
| 133 | respiratory chain complex IV assembly (GO:0008535) | 2.68244392 |
| 134 | negative regulation of B cell apoptotic process (GO:0002903) | 2.67378693 |
| 135 | response to interferon-beta (GO:0035456) | 2.63039033 |
| 136 | porphyrin-containing compound metabolic process (GO:0006778) | 2.62901994 |
| 137 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.62784874 |
| 138 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.60710745 |
| 139 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.59056056 |
| 140 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.58282455 |
| 141 | immunoglobulin mediated immune response (GO:0016064) | 2.56804500 |
| 142 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.56166767 |
| 143 | hemoglobin metabolic process (GO:0020027) | 2.54519537 |
| 144 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.54369961 |
| 145 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.53000652 |
| 146 | deoxyribose phosphate metabolic process (GO:0019692) | 2.52911403 |
| 147 | regulation of B cell apoptotic process (GO:0002902) | 2.52543197 |
| 148 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.51051104 |
| 149 | purine nucleotide salvage (GO:0032261) | 2.50082354 |
| 150 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.49995231 |
| 151 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.48297206 |
| 152 | DNA deamination (GO:0045006) | 2.47637656 |
| 153 | branched-chain amino acid catabolic process (GO:0009083) | 2.46774564 |
| 154 | tetrapyrrole biosynthetic process (GO:0033014) | 2.45783208 |
| 155 | phenylpropanoid metabolic process (GO:0009698) | 2.45103594 |
| 156 | plasma lipoprotein particle organization (GO:0071827) | 2.44022606 |
| 157 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.42591577 |
| 158 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.41622261 |
| 159 | purine-containing compound salvage (GO:0043101) | 2.41449221 |
| 160 | S-adenosylmethionine metabolic process (GO:0046500) | 2.39988477 |
| 161 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.39765372 |
| 162 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.38082104 |
| 163 | glutathione biosynthetic process (GO:0006750) | 2.37473302 |
| 164 | branched-chain amino acid metabolic process (GO:0009081) | 2.37051952 |
| 165 | glutathione metabolic process (GO:0006749) | 2.35542587 |
| 166 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.34354395 |
| 167 | ubiquinone biosynthetic process (GO:0006744) | 2.34269464 |
| 168 | glutathione derivative biosynthetic process (GO:1901687) | 2.33433606 |
| 169 | glutathione derivative metabolic process (GO:1901685) | 2.33433606 |
| 170 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.31469199 |
| 171 | regulation of mitochondrial fission (GO:0090140) | 2.31055834 |
| 172 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.30859047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.60595265 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.69566887 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.59363555 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.68692731 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.34957979 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80360962 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.65080758 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.23260861 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.56684291 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.09859453 |
| 11 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44548764 |
| 12 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42593044 |
| 13 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.34845344 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.29580005 |
| 15 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.25126145 |
| 16 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.23377216 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.14746234 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09575297 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04977901 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02184171 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0884355 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96041440 |
| 23 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93436781 |
| 24 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.85233157 |
| 25 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74844823 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73073218 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71712993 |
| 28 | * P68_20966046_ChIP-Seq_HELA_Human | 1.71297441 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.70415285 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.68939017 |
| 31 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68837604 |
| 32 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.58717298 |
| 33 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.58529300 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.56370801 |
| 35 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.52284442 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49832765 |
| 37 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.49155051 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49135136 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.46721072 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45590484 |
| 41 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.42551436 |
| 42 | * P300_27268052_Chip-Seq_Bcells_Human | 1.42408347 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40851717 |
| 44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.40486288 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38316674 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.38054069 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36232580 |
| 48 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.36143434 |
| 49 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.33444221 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32419555 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30963968 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.30299231 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29443812 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.29276834 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27566842 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27465799 |
| 57 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.25884137 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.25034700 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.24905991 |
| 60 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.24461066 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24291894 |
| 62 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.23809534 |
| 63 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.23675014 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23612034 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21315722 |
| 66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20177175 |
| 67 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.19835858 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19502380 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18661430 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18041260 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16977835 |
| 72 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15182619 |
| 73 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.15015931 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14640591 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14453003 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13978524 |
| 77 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13735724 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13580863 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12547446 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 1.12027033 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11908397 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11202509 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10167904 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10083928 |
| 85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09523017 |
| 86 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.09435290 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08250707 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07441253 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05863709 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05496807 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05101893 |
| 92 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.04740994 |
| 93 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04630044 |
| 94 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04362729 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02351195 |
| 96 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02225358 |
| 97 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.01894785 |
| 98 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.97855259 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97581667 |
| 100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92323805 |
| 101 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.91709651 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90287737 |
| 103 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88734311 |
| 104 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86018138 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84317912 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84251559 |
| 107 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83442877 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82848582 |
| 109 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.82162715 |
| 110 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.80540378 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78635940 |
| 112 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.78626447 |
| 113 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78204856 |
| 114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77527020 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75855357 |
| 116 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75398029 |
| 117 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.74870027 |
| 118 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.73555375 |
| 119 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69216006 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67742707 |
| 121 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.67407204 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.66673903 |
| 123 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.66328509 |
| 124 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.65146253 |
| 125 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.60942846 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60767834 |
| 127 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60566705 |
| 128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.60361991 |
| 129 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.58610379 |
| 130 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.57900097 |
| 131 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.57779260 |
| 132 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.57457325 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57305772 |
| 134 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.56138721 |
| 135 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55936708 |
| 136 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.55913655 |
| 137 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.55301762 |
| 138 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.52744597 |
| 139 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.52151022 |
| 140 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.51668762 |
| 141 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51230168 |
| 142 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.51205675 |
| 143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51104262 |
| 144 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.50986402 |
| 145 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.50548876 |
| 146 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.50259050 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.50258610 |
| 148 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.49659051 |
| 149 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49365837 |
| 150 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.48168593 |
| 151 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.48054192 |
| 152 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.47947440 |
| 153 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47910883 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.47637452 |
| 155 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.47637452 |
| 156 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47615169 |
| 157 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47234771 |
| 158 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46456870 |
| 159 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46347195 |
| 160 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.46270165 |
| 161 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.46103927 |
| 162 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.46084287 |
| 163 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45917926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.84348603 |
| 2 | MP0005360_urolithiasis | 7.31542273 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.01313380 |
| 4 | MP0005365_abnormal_bile_salt | 5.85444706 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 5.12515328 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05210614 |
| 7 | MP0003252_abnormal_bile_duct | 3.56499342 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.23347097 |
| 9 | MP0009840_abnormal_foam_cell | 3.00425810 |
| 10 | MP0005332_abnormal_amino_acid | 2.96096311 |
| 11 | MP0003195_calcinosis | 2.93825528 |
| 12 | MP0009278_abnormal_bone_marrow | 2.83917389 |
| 13 | MP0005083_abnormal_biliary_tract | 2.75471966 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.54170659 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.45166096 |
| 16 | MP0001545_abnormal_hematopoietic_system | 2.42944786 |
| 17 | MP0005397_hematopoietic_system_phenotyp | 2.42944786 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.34410080 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.30217699 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.24287724 |
| 21 | MP0000609_abnormal_liver_physiology | 2.02562494 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.01973796 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.96341956 |
| 24 | MP0003186_abnormal_redox_activity | 1.94267092 |
| 25 | MP0000465_gastrointestinal_hemorrhage | 1.86957163 |
| 26 | MP0001764_abnormal_homeostasis | 1.83025100 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.82480018 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.78117124 |
| 29 | MP0005451_abnormal_body_composition | 1.70739952 |
| 30 | MP0003011_delayed_dark_adaptation | 1.67778353 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.66957817 |
| 32 | MP0003868_abnormal_feces_composition | 1.66013352 |
| 33 | MP0008995_early_reproductive_senescence | 1.63819812 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.59720952 |
| 35 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.58570681 |
| 36 | MP0002653_abnormal_ependyma_morphology | 1.53653245 |
| 37 | MP0009697_abnormal_copulation | 1.52102561 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.51039940 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.49420751 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.43613693 |
| 41 | MP0008260_abnormal_autophagy | 1.43156835 |
| 42 | MP0002419_abnormal_innate_immunity | 1.36220680 |
| 43 | MP0005387_immune_system_phenotype | 1.33884796 |
| 44 | MP0001790_abnormal_immune_system | 1.33884796 |
| 45 | MP0001873_stomach_inflammation | 1.33045571 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.27158143 |
| 47 | MP0001800_abnormal_humoral_immune | 1.23328278 |
| 48 | MP0002723_abnormal_immune_serum | 1.22944833 |
| 49 | MP0005671_abnormal_response_to | 1.22944043 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.19578690 |
| 51 | MP0000598_abnormal_liver_morphology | 1.17486013 |
| 52 | MP0001835_abnormal_antigen_presentation | 1.15237728 |
| 53 | * MP0005636_abnormal_mineral_homeostasis | 1.13477402 |
| 54 | MP0003303_peritoneal_inflammation | 1.12229185 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.11354796 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.11285699 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.10241612 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.09513507 |
| 59 | MP0001819_abnormal_immune_cell | 1.09101736 |
| 60 | MP0009764_decreased_sensitivity_to | 1.07747241 |
| 61 | MP0002822_catalepsy | 1.07385918 |
| 62 | MP0005408_hypopigmentation | 1.04960982 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.03436260 |
| 64 | MP0005410_abnormal_fertilization | 1.03365875 |
| 65 | MP0008469_abnormal_protein_level | 1.01092018 |
| 66 | MP0009763_increased_sensitivity_to | 1.00903805 |
| 67 | MP0003724_increased_susceptibility_to | 1.00649714 |
| 68 | MP0005647_abnormal_sex_gland | 1.00587187 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 0.99738358 |
| 70 | MP0000685_abnormal_immune_system | 0.97760164 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 0.95352746 |
| 72 | MP0000604_amyloidosis | 0.93715216 |
| 73 | MP0003786_premature_aging | 0.93415362 |
| 74 | MP0002405_respiratory_system_inflammati | 0.92897494 |
| 75 | MP0005670_abnormal_white_adipose | 0.92195396 |
| 76 | MP0001905_abnormal_dopamine_level | 0.92151432 |
| 77 | MP0001529_abnormal_vocalization | 0.91771477 |
| 78 | MP0002933_joint_inflammation | 0.88306105 |
| 79 | MP0010368_abnormal_lymphatic_system | 0.87903782 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.86695248 |
| 81 | MP0005376_homeostasis/metabolism_phenot | 0.86391447 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.85479856 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.85263024 |
| 84 | MP0002722_abnormal_immune_system | 0.85034134 |
| 85 | MP0000372_irregular_coat_pigmentation | 0.83987776 |
| 86 | MP0000716_abnormal_immune_system | 0.83749658 |
| 87 | MP0000516_abnormal_urinary_system | 0.83145927 |
| 88 | MP0005367_renal/urinary_system_phenotyp | 0.83145927 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.81681692 |
| 90 | MP0002693_abnormal_pancreas_physiology | 0.78809189 |
| 91 | MP0003690_abnormal_glial_cell | 0.78662071 |
| 92 | MP0002429_abnormal_blood_cell | 0.77347240 |
| 93 | MP0001661_extended_life_span | 0.76997358 |
| 94 | MP0001756_abnormal_urination | 0.76933434 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.76690594 |
| 96 | MP0002132_abnormal_respiratory_system | 0.76167247 |
| 97 | MP0002254_reproductive_system_inflammat | 0.75707066 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.73634019 |
| 99 | MP0006082_CNS_inflammation | 0.73157320 |
| 100 | MP0005266_abnormal_metabolism | 0.72812147 |
| 101 | MP0003718_maternal_effect | 0.69153562 |
| 102 | MP0004043_abnormal_pH_regulation | 0.65602809 |
| 103 | MP0004147_increased_porphyrin_level | 0.65013402 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.63404909 |
| 105 | MP0004381_abnormal_hair_follicle | 0.62823851 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.60667596 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.59595065 |
| 108 | MP0003329_amyloid_beta_deposits | 0.57858116 |
| 109 | MP0003705_abnormal_hypodermis_morpholog | 0.57303750 |
| 110 | MP0005395_other_phenotype | 0.55414790 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.55268614 |
| 112 | MP0009379_abnormal_foot_pigmentation | 0.55121437 |
| 113 | MP0009053_abnormal_anal_canal | 0.54933406 |
| 114 | MP0008873_increased_physiological_sensi | 0.53304832 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.53291626 |
| 116 | MP0005334_abnormal_fat_pad | 0.51158050 |
| 117 | MP0005535_abnormal_body_temperature | 0.50983623 |
| 118 | MP0001853_heart_inflammation | 0.50919926 |
| 119 | MP0002971_abnormal_brown_adipose | 0.50180299 |
| 120 | MP0005464_abnormal_platelet_physiology | 0.47281348 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.47041697 |
| 122 | MP0008872_abnormal_physiological_respon | 0.43681946 |
| 123 | MP0003436_decreased_susceptibility_to | 0.41879441 |
| 124 | MP0001243_abnormal_dermal_layer | 0.40562959 |
| 125 | MP0001845_abnormal_inflammatory_respons | 0.39696744 |
| 126 | MP0009384_cardiac_valve_regurgitation | 0.39166477 |
| 127 | MP0004130_abnormal_muscle_cell | 0.39014294 |
| 128 | MP0009785_altered_susceptibility_to | 0.38162715 |
| 129 | MP0001542_abnormal_bone_strength | 0.37281978 |
| 130 | MP0002796_impaired_skin_barrier | 0.36504177 |
| 131 | MP0005075_abnormal_melanosome_morpholog | 0.34649448 |
| 132 | MP0003075_altered_response_to | 0.34549378 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.34457642 |
| 134 | MP0000566_synostosis | 0.34249067 |
| 135 | MP0005166_decreased_susceptibility_to | 0.34120071 |
| 136 | MP0005448_abnormal_energy_balance | 0.33719278 |
| 137 | MP0002295_abnormal_pulmonary_circulatio | 0.32692879 |
| 138 | MP0005025_abnormal_response_to | 0.31594805 |
| 139 | MP0003953_abnormal_hormone_level | 0.30371963 |
| 140 | MP0005666_abnormal_adipose_tissue | 0.30093491 |
| 141 | MP0002060_abnormal_skin_morphology | 0.29804965 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.29203805 |
| 143 | MP0000249_abnormal_blood_vessel | 0.28846099 |
| 144 | MP0000920_abnormal_myelination | 0.28379609 |
| 145 | MP0005164_abnormal_response_to | 0.28337262 |
| 146 | MP0002168_other_aberrant_phenotype | 0.27216657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.31706750 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.65704430 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.26138187 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.04489005 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.83633062 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.81361155 |
| 7 | Xanthomatosis (HP:0000991) | 5.55803505 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.94371302 |
| 9 | Hyperammonemia (HP:0001987) | 4.48735484 |
| 10 | Complement deficiency (HP:0004431) | 4.39570212 |
| 11 | Hyperglycinemia (HP:0002154) | 4.36782443 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.19005264 |
| 13 | Hepatocellular necrosis (HP:0001404) | 4.17597663 |
| 14 | Abnormality of methionine metabolism (HP:0010901) | 4.06396460 |
| 15 | Joint hemorrhage (HP:0005261) | 4.05651591 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.04060670 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.04060670 |
| 18 | Hyperglycinuria (HP:0003108) | 4.01033269 |
| 19 | Ketosis (HP:0001946) | 4.00220028 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.98983538 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.95601293 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.92905272 |
| 23 | Fat malabsorption (HP:0002630) | 3.92763228 |
| 24 | Petechiae (HP:0000967) | 3.88801387 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.86341293 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.86053362 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.85485307 |
| 28 | Epidermoid cyst (HP:0200040) | 3.80544205 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.70231391 |
| 30 | Mitochondrial inheritance (HP:0001427) | 3.59917770 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59527788 |
| 32 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.55693764 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.53950544 |
| 34 | Delayed CNS myelination (HP:0002188) | 3.53181834 |
| 35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.50771900 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.49675015 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 3.44586429 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.32159961 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.29735494 |
| 40 | Cerebral edema (HP:0002181) | 3.26773311 |
| 41 | Steatorrhea (HP:0002570) | 3.21197889 |
| 42 | Abnormality of complement system (HP:0005339) | 3.17962683 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 3.14959870 |
| 44 | Acute necrotizing encephalopathy (HP:0006965) | 3.12158054 |
| 45 | Cerebral palsy (HP:0100021) | 3.10423226 |
| 46 | Lethargy (HP:0001254) | 3.09275268 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.07730768 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 3.07730768 |
| 49 | Hypercholesterolemia (HP:0003124) | 3.00158492 |
| 50 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.99571058 |
| 51 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.99571058 |
| 52 | Increased CSF lactate (HP:0002490) | 2.97205119 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.96902477 |
| 54 | Metabolic acidosis (HP:0001942) | 2.95129872 |
| 55 | Obstructive lung disease (HP:0006536) | 2.91450107 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91450107 |
| 57 | Increased muscle lipid content (HP:0009058) | 2.88082034 |
| 58 | Increased intramyocellular lipid droplets (HP:0012240) | 2.81543387 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80568976 |
| 60 | Ketoacidosis (HP:0001993) | 2.77960188 |
| 61 | Ragged-red muscle fibers (HP:0003200) | 2.76860740 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.76713851 |
| 63 | Purpura (HP:0000979) | 2.71743625 |
| 64 | Retinal atrophy (HP:0001105) | 2.70731719 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.67959522 |
| 66 | Acute encephalopathy (HP:0006846) | 2.65970471 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.65589822 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.64228349 |
| 69 | Epistaxis (HP:0000421) | 2.63797800 |
| 70 | Agammaglobulinemia (HP:0004432) | 2.63563166 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.61904320 |
| 72 | Vascular calcification (HP:0004934) | 2.58814699 |
| 73 | Progressive macrocephaly (HP:0004481) | 2.48378938 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48280905 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48280905 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48280905 |
| 77 | Vomiting (HP:0002013) | 2.47094756 |
| 78 | Lactic acidosis (HP:0003128) | 2.46770312 |
| 79 | Opisthotonus (HP:0002179) | 2.44991912 |
| 80 | Gout (HP:0001997) | 2.44801401 |
| 81 | Stomatitis (HP:0010280) | 2.41242246 |
| 82 | Brushfield spots (HP:0001088) | 2.41189132 |
| 83 | Spontaneous abortion (HP:0005268) | 2.40442256 |
| 84 | Glycosuria (HP:0003076) | 2.37668716 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 2.37668716 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 2.36091768 |
| 87 | Hypoglycemic seizures (HP:0002173) | 2.35807355 |
| 88 | Dysostosis multiplex (HP:0000943) | 2.35172507 |
| 89 | Irritability (HP:0000737) | 2.34809773 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 2.33561077 |
| 91 | Spastic diplegia (HP:0001264) | 2.30641088 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 2.28931086 |
| 93 | Malnutrition (HP:0004395) | 2.28628844 |
| 94 | Severe visual impairment (HP:0001141) | 2.28554887 |
| 95 | Hepatic necrosis (HP:0002605) | 2.27315343 |
| 96 | Progressive microcephaly (HP:0000253) | 2.26799264 |
| 97 | Skin nodule (HP:0200036) | 2.26537499 |
| 98 | Acanthocytosis (HP:0001927) | 2.26488938 |
| 99 | Increased serum lactate (HP:0002151) | 2.26051301 |
| 100 | Cardiovascular calcification (HP:0011915) | 2.25999753 |
| 101 | Cholelithiasis (HP:0001081) | 2.24906223 |
| 102 | Amyloidosis (HP:0011034) | 2.24844114 |
| 103 | Myocardial infarction (HP:0001658) | 2.21580915 |
| 104 | Increased serum ferritin (HP:0003281) | 2.21087539 |
| 105 | Myositis (HP:0100614) | 2.20556959 |
| 106 | Panhypogammaglobulinemia (HP:0003139) | 2.20536887 |
| 107 | Abnormal gallbladder physiology (HP:0012438) | 2.20485024 |
| 108 | Cholecystitis (HP:0001082) | 2.20485024 |
| 109 | Hypochromic microcytic anemia (HP:0004840) | 2.20356679 |
| 110 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.19563068 |
| 111 | Enlarged kidneys (HP:0000105) | 2.17436693 |
| 112 | Renal cortical cysts (HP:0000803) | 2.17225129 |
| 113 | Abnormality of the prostate (HP:0008775) | 2.16401923 |
| 114 | Proximal tubulopathy (HP:0000114) | 2.15807490 |
| 115 | Hepatosplenomegaly (HP:0001433) | 2.14835409 |
| 116 | Alkalosis (HP:0001948) | 2.14375974 |
| 117 | Pancreatitis (HP:0001733) | 2.14204225 |
| 118 | Renal Fanconi syndrome (HP:0001994) | 2.13281560 |
| 119 | Abnormal pupillary function (HP:0007686) | 2.12943009 |
| 120 | Tubulointerstitial nephritis (HP:0001970) | 2.12069837 |
| 121 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10611400 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10611400 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10611400 |
| 124 | Emotional lability (HP:0000712) | 2.08777677 |
| 125 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08667679 |
| 126 | 3-Methylglutaconic aciduria (HP:0003535) | 2.08574589 |
| 127 | J-shaped sella turcica (HP:0002680) | 2.07380582 |
| 128 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.06157963 |
| 129 | Neonatal onset (HP:0003623) | 2.04728209 |
| 130 | Increased serum pyruvate (HP:0003542) | 2.04309239 |
| 131 | Abnormality of glycolysis (HP:0004366) | 2.04309239 |
| 132 | Bile duct proliferation (HP:0001408) | 2.01438382 |
| 133 | Abnormal biliary tract physiology (HP:0012439) | 2.01438382 |
| 134 | Increased cerebral lipofuscin (HP:0011813) | 2.00787277 |
| 135 | Mesangial abnormality (HP:0001966) | 2.00542938 |
| 136 | Episodic fever (HP:0001954) | 1.99469033 |
| 137 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98694915 |
| 138 | Glomerulonephritis (HP:0000099) | 1.98063207 |
| 139 | Rickets (HP:0002748) | 1.95861970 |
| 140 | Respiratory failure (HP:0002878) | 1.95625904 |
| 141 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95624460 |
| 142 | Stridor (HP:0010307) | 1.95482950 |
| 143 | Progressive neurologic deterioration (HP:0002344) | 1.95451971 |
| 144 | Abnormal cartilage morphology (HP:0002763) | 1.95146717 |
| 145 | Spastic paraparesis (HP:0002313) | 1.94706403 |
| 146 | Loss of speech (HP:0002371) | 1.94214262 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.92447296 |
| 148 | Elevated hepatic transaminases (HP:0002910) | 1.91129232 |
| 149 | Gingival bleeding (HP:0000225) | 1.90872514 |
| 150 | Nausea (HP:0002018) | 1.89835957 |
| 151 | Recurrent fungal infections (HP:0002841) | 1.89476166 |
| 152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89310352 |
| 153 | Mitral stenosis (HP:0001718) | 1.88668163 |
| 154 | Mediastinal lymphadenopathy (HP:0100721) | 1.87906407 |
| 155 | CNS demyelination (HP:0007305) | 1.87518433 |
| 156 | Abnormality of the gallbladder (HP:0005264) | 1.87505991 |
| 157 | Menorrhagia (HP:0000132) | 1.87489185 |
| 158 | Recurrent abscess formation (HP:0002722) | 1.86611071 |
| 159 | Poikilocytosis (HP:0004447) | 1.85407761 |
| 160 | Skin rash (HP:0000988) | 1.84958107 |
| 161 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84439402 |
| 162 | Abnormality of macrophages (HP:0004311) | 1.84432257 |
| 163 | Abnormality of lateral ventricle (HP:0030047) | 1.83575736 |
| 164 | Hypophosphatemic rickets (HP:0004912) | 1.83212861 |
| 165 | Abnormality of vitamin metabolism (HP:0100508) | 1.82996138 |
| 166 | Exercise intolerance (HP:0003546) | 1.82585922 |
| 167 | Methylmalonic aciduria (HP:0012120) | 1.80652492 |
| 168 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80522642 |
| 169 | Mucopolysacchariduria (HP:0008155) | 1.80522642 |
| 170 | Meningitis (HP:0001287) | 1.80478854 |
| 171 | Hyperthyroidism (HP:0000836) | 1.77754469 |
| 172 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.77585832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.17574613 |
| 2 | ERN1 | 4.10227276 |
| 3 | FGFR4 | 4.01122201 |
| 4 | MAP4K2 | 3.25798586 |
| 5 | SIK1 | 3.06246338 |
| 6 | VRK2 | 2.85877500 |
| 7 | TNK2 | 2.83347661 |
| 8 | NME2 | 2.72624326 |
| 9 | TIE1 | 2.49433175 |
| 10 | KDR | 2.36173191 |
| 11 | CDK19 | 2.34894185 |
| 12 | STK16 | 2.32550195 |
| 13 | PIK3CG | 2.19657088 |
| 14 | ERBB4 | 2.18919611 |
| 15 | PBK | 2.11368618 |
| 16 | IRAK3 | 2.09569876 |
| 17 | FLT3 | 1.97532663 |
| 18 | TYK2 | 1.93343338 |
| 19 | CCNB1 | 1.93237361 |
| 20 | WNK4 | 1.91931732 |
| 21 | INSRR | 1.91165456 |
| 22 | ABL2 | 1.88217428 |
| 23 | MST1R | 1.64276979 |
| 24 | TAOK3 | 1.62873275 |
| 25 | MAPK11 | 1.56204895 |
| 26 | DAPK1 | 1.48731942 |
| 27 | RIPK4 | 1.46646851 |
| 28 | MET | 1.39416482 |
| 29 | TBK1 | 1.37677003 |
| 30 | OXSR1 | 1.37570243 |
| 31 | TESK1 | 1.33135048 |
| 32 | STK39 | 1.30533559 |
| 33 | MAPK15 | 1.27535012 |
| 34 | MYLK | 1.21520945 |
| 35 | EIF2AK1 | 1.21266206 |
| 36 | IKBKE | 1.19342357 |
| 37 | SYK | 1.16950386 |
| 38 | MAP3K3 | 1.14241651 |
| 39 | NEK9 | 1.12202498 |
| 40 | TESK2 | 1.10968258 |
| 41 | FES | 1.08525058 |
| 42 | MATK | 1.04854166 |
| 43 | PRKD2 | 1.04577116 |
| 44 | MAPKAPK3 | 1.03755700 |
| 45 | EPHB1 | 0.99935175 |
| 46 | PINK1 | 0.97244775 |
| 47 | MAPK4 | 0.96545538 |
| 48 | CAMK2G | 0.93832935 |
| 49 | IRAK2 | 0.93387801 |
| 50 | NUAK1 | 0.93369536 |
| 51 | GRK5 | 0.91373743 |
| 52 | GRK6 | 0.89977543 |
| 53 | MAP2K2 | 0.89048321 |
| 54 | BLK | 0.86788828 |
| 55 | KIT | 0.85194466 |
| 56 | STK38L | 0.83841518 |
| 57 | JAK2 | 0.79672233 |
| 58 | MAP2K6 | 0.79563576 |
| 59 | MAP3K11 | 0.78398614 |
| 60 | ZAK | 0.78000484 |
| 61 | ERBB2 | 0.77669718 |
| 62 | MAP3K14 | 0.77277891 |
| 63 | MAP2K4 | 0.76267143 |
| 64 | EIF2AK3 | 0.75537492 |
| 65 | TLK1 | 0.72386846 |
| 66 | TAOK1 | 0.71777038 |
| 67 | GRK7 | 0.70771978 |
| 68 | IRAK1 | 0.70647867 |
| 69 | CSNK1G1 | 0.70282351 |
| 70 | CSNK1G3 | 0.70072856 |
| 71 | BMX | 0.70068610 |
| 72 | PIM2 | 0.69066451 |
| 73 | LCK | 0.68812917 |
| 74 | MAP3K1 | 0.68777469 |
| 75 | GRK1 | 0.67533492 |
| 76 | MAP3K7 | 0.66812700 |
| 77 | BUB1 | 0.66735331 |
| 78 | CSNK1G2 | 0.66339417 |
| 79 | PIK3CA | 0.66011458 |
| 80 | HIPK2 | 0.65399189 |
| 81 | MAPK12 | 0.65062350 |
| 82 | PTK2B | 0.64822398 |
| 83 | VRK1 | 0.63394393 |
| 84 | GSK3A | 0.61003603 |
| 85 | IKBKB | 0.60417643 |
| 86 | MAP4K1 | 0.60409762 |
| 87 | PRKCZ | 0.59970935 |
| 88 | SIK2 | 0.59948756 |
| 89 | PDK1 | 0.58968746 |
| 90 | PIM1 | 0.58542477 |
| 91 | RPS6KA4 | 0.58015678 |
| 92 | DYRK1B | 0.56442163 |
| 93 | IRAK4 | 0.55469003 |
| 94 | PDPK1 | 0.55242346 |
| 95 | FRK | 0.53952126 |
| 96 | TAOK2 | 0.53292252 |
| 97 | CSK | 0.53251261 |
| 98 | PRKCQ | 0.53206798 |
| 99 | MAPK7 | 0.53141454 |
| 100 | MAPK13 | 0.53092136 |
| 101 | PTK6 | 0.52893069 |
| 102 | RPS6KA5 | 0.52527370 |
| 103 | PRKAA2 | 0.52065082 |
| 104 | PRKACG | 0.51462237 |
| 105 | PKN1 | 0.50523897 |
| 106 | EPHA2 | 0.49945715 |
| 107 | MAP2K3 | 0.48784310 |
| 108 | TGFBR2 | 0.47112323 |
| 109 | CSF1R | 0.46613428 |
| 110 | MAPKAPK2 | 0.46493756 |
| 111 | LRRK2 | 0.46262798 |
| 112 | ADRBK1 | 0.45732808 |
| 113 | FGFR2 | 0.45444448 |
| 114 | ITK | 0.44588747 |
| 115 | ACVR1B | 0.44365221 |
| 116 | CSNK1A1 | 0.43515737 |
| 117 | TXK | 0.41921735 |
| 118 | PRKG2 | 0.40246429 |
| 119 | JAK1 | 0.39284758 |
| 120 | TEC | 0.38365011 |
| 121 | RPS6KA6 | 0.37779785 |
| 122 | NME1 | 0.37743406 |
| 123 | ADRBK2 | 0.37190451 |
| 124 | PRKCD | 0.36835028 |
| 125 | MAP2K7 | 0.36507468 |
| 126 | RPS6KC1 | 0.36056258 |
| 127 | RPS6KL1 | 0.36056258 |
| 128 | MAPK3 | 0.35713146 |
| 129 | IGF1R | 0.35546571 |
| 130 | JAK3 | 0.35069046 |
| 131 | CSNK2A1 | 0.34529809 |
| 132 | DAPK3 | 0.34140390 |
| 133 | CSNK1A1L | 0.33599796 |
| 134 | LYN | 0.32211273 |
| 135 | ZAP70 | 0.32113005 |
| 136 | PDK2 | 0.31163825 |
| 137 | DAPK2 | 0.30464063 |
| 138 | PDK3 | 0.29773089 |
| 139 | PDK4 | 0.29773089 |
| 140 | BTK | 0.29739857 |
| 141 | PKN2 | 0.28611054 |
| 142 | LATS1 | 0.28488930 |
| 143 | MAP2K1 | 0.26337266 |
| 144 | DYRK2 | 0.25771280 |
| 145 | PRKCA | 0.25537205 |
| 146 | BCR | 0.24945961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.06243786 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.07699857 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87625452 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.87327253 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75242605 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70033611 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67498354 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.67058722 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52798358 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52184279 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37900979 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.34124957 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20233800 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.19248631 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.19223966 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15128114 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03935183 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98395141 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.97509078 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97088514 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96858930 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85737155 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79065764 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.77185146 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75498671 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75006639 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74469858 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74200991 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.73315424 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73291216 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71381583 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68295166 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68168120 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66732468 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61083901 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.58564061 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.57665055 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54457073 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53469566 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48060842 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47438555 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47073408 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.44563337 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43947608 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41800376 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41329195 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.41132755 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 1.32891117 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30400062 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23812837 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.23384563 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23085941 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.23020222 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17291328 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17236261 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15593369 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14896160 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 1.13586658 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11937915 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10170759 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 1.06933160 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06272265 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03088680 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02993443 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01426803 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00687432 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.99740186 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.99367208 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95812020 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94123537 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93018018 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92304201 |
| 73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88898500 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80737309 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79117901 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77631285 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74158486 |
| 78 | Homologous recombination_Homo sapiens_hsa03440 | 0.73373384 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72334481 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71202260 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67462972 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65098365 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63724762 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63295589 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.59250223 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55972762 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52065541 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.51508793 |
| 89 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50739961 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50663933 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.50177361 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46876083 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.45740165 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44888566 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44675647 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.44012997 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42126864 |
| 98 | Proteasome_Homo sapiens_hsa03050 | 0.41577384 |
| 99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40470238 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38792195 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35919534 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29829416 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28666758 |
| 104 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28624087 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26497422 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24121130 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.19095805 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.18678487 |
| 109 | Ribosome_Homo sapiens_hsa03010 | 0.15490196 |
| 110 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.14380267 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10836557 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09687470 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.08894148 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05003159 |
| 115 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1752980 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1571889 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1522816 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1427096 |
| 119 | Purine metabolism_Homo sapiens_hsa00230 | -0.1342176 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1335588 |
| 121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.1189457 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0754963 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0658442 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0572504 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | -0.0189860 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0094453 |

